Amyloid Imaging with PET in Early Alzheimer Disease Diagnosis
Christopher C Rowe, Victor L Villemagne
MEDICAL CLINICS OF NORTH AMERICA | W B SAUNDERS CO-ELSEVIER INC | Published : 2013
In vivo imaging of amyloid-β (Aβ) with positron emission tomography has moved from the research arena into clinical practice. Clinicians working with cognitive decline and dementia must become familiar with its benefits and limitations. Amyloid imaging allows earlier diagnosis of Alzheimer disease and better differential diagnosis of dementia and provides prognostic information for mild cognitive impairment. It also has an increasingly important role in therapeutic trial recruitment and for evaluation of anti-Aβ treatments. Longitudinal observations are required to elucidate the role of Aβ deposition in the course of Alzheimer disease and provide information needed to fully use the prognosti..View full abstract
Related Projects (1)
Awarded by National Health and Medical Research Council of Australia
This work was supported in part by grant 1011689 of the National Health and Medical Research Council of Australia, the Science and Industry Endowment Fund, and the Austin Hospital Medical Research Foundation.